ADTX is down -50%. Find out why the stock tumbled today.

Aditxt Inc (ADTX) is trading -50% lower at $5.2 today. While it's generally been a somewhat dispirited day for this part of the market, the company is underperforming it's peers in the Health Care sector.

-Aditxt (ADTX) recently announced a 1-for-50 reverse split.

Aditxt Inc has been trading between a 52-week high of $136 and a 52-week low of $5.17. The stock has a market cap of $296 Million.

Aditxt is developing technologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming. The immune monitoring technology is designed to provide a personalized comprehensive profile of the immune system. The immune reprogramming technology is currently at the pre-clinical stage and is designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted organs, autoimmune diseases, and allergies.